Djurdjevic-Pahl Aleksandra, Hewage Chandralal, Malthouse J Paul G
Department of Biochemistry, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.
Biochem J. 2002 Mar 1;362(Pt 2):339-47. doi: 10.1042/0264-6021:3620339.
A new inhibitor, Z-Ala-Pro-Phe-glyoxal (where Z is benzyloxycarbonyl),has been synthesized and shown to be a competitive inhibitor of delta-chymotrypsin, with a K(i) of 25+/-8 nM at pH 7.0 and 25 degrees C. Z-Ala-Pro-[1-(13)C]Phe-glyoxal and Z-Ala-Pro-[2-(13)C]Phe-glyoxal have been synthesized, and (13)C-NMR has been used to determine how they interact with delta-chymotrypsin. Using Z-Ala-Pro-[2-(13)C]Phe-glyoxal we have detected a signal at 100.7 p.p.m. which we assign to the tetrahedral adduct formed between the hydroxy group of Ser-195 and the (13)C-enriched keto-carbon of the inhibitor. This signal is in a pH-dependent slow exchange with a signal at 107.6 p.p.m. which depends on a pK(a) of approximately 4.5, which we assign to oxyanion formation. Thus we are the first to detect an oxyanion pK(a) in a reversible chymotrypsin-inhibitor complex. A smaller titration shift of 100.7 p.p.m. to 103.9 p.p.m. with a pK(a) of approximately 5.3 is also detected due to a rapid exchange process. This pK(a) is also detected with the Z-Ala-Pro-[1-(13)C]Phe-glyoxal inhibitor and gives a larger titration shift of 91.4 p.p.m. to 97.3 p.p.m., which we assign to the ionization of the hydrated aldehyde hydroxy groups of the enzyme-bound inhibitor. Protonation of the oxyanion in the oxyanion hole decreases the binding efficiency of the inhibitor. From this decrease in binding efficiency we estimate that oxyanion binding in the oxyanion hole reduces the oxyanion pK(a) by 1.3 pK(a) units. We calculate that the pK(a)s of the oxyanions of the hemiketal and hydrated aldehyde moieties of the glyoxal inhibitor are both lowered by 6.4-6.9 pK(a) units on binding to chymotrypsin. Therefore we conclude that oxyanion binding in the oxyanion hole has only a minor role in decreasing the oxyanion pK(a). We also investigate how the inhibitor breaks down at alkaline pH, and how it breaks down at neutral pH in the presence of chymotrypsin.
一种新的抑制剂Z-丙氨酰-脯氨酰-苯丙氨酰乙二醛(其中Z为苄氧羰基)已被合成,并被证明是δ-胰凝乳蛋白酶的竞争性抑制剂,在pH 7.0和25℃时K(i)为25±8 nM。已合成Z-丙氨酰-脯氨酰-[1-(13)C]苯丙氨酰乙二醛和Z-丙氨酰-脯氨酰-[2-(13)C]苯丙氨酰乙二醛,并利用(13)C-核磁共振来确定它们与δ-胰凝乳蛋白酶的相互作用方式。使用Z-丙氨酰-脯氨酰-[2-(13)C]苯丙氨酰乙二醛时,我们在100.7 ppm处检测到一个信号,我们将其归属于Ser-195的羟基与抑制剂中富含(13)C的酮羰基形成的四面体加合物。该信号与107.6 ppm处的一个信号进行pH依赖性的缓慢交换,后者取决于约4.5的pK(a),我们将其归属于氧负离子的形成。因此,我们是首个在可逆的胰凝乳蛋白酶-抑制剂复合物中检测到氧负离子pK(a)的。由于快速交换过程,还检测到从100.7 ppm到103.9 ppm的较小滴定位移,其pK(a)约为5.3。使用Z-丙氨酰-脯氨酰-[1-(13)C]苯丙氨酰乙二醛抑制剂时也检测到这个pK(a),并给出从91.4 ppm到97.3 ppm的较大滴定位移,我们将其归属于酶结合抑制剂的水合醛羟基的电离。氧负离子孔中氧负离子的质子化降低了抑制剂的结合效率。根据这种结合效率的降低,我们估计氧负离子孔中氧负离子的结合使氧负离子pK(a)降低了1.3个pK(a)单位。我们计算得出,乙二醛抑制剂的半缩酮和水合醛部分的氧负离子的pK(a)在与胰凝乳蛋白酶结合时均降低了6.4 - 6.9个pK(a)单位。因此我们得出结论,氧负离子孔中氧负离子的结合在降低氧负离子pK(a)方面仅起次要作用。我们还研究了该抑制剂在碱性pH下以及在中性pH且存在胰凝乳蛋白酶的情况下如何分解。